Records 1 - 25
| Association between certain non-small cell lung cancer driver mutations and predictive markers for chemotherapy or programmed death-ligand 1 inhibition.
Cancer science 2019 Apr .
Liang Wenhua, Guo Minzhang, Pan Zhenkui, Cai Xiuyu, Li Caichen, Zhao Yi, Liang Hengrui, Yang Haiying, Wang Zhen, Chen Wenting, Xu Chuhong, Yang Xinyun, Sun Jianyu, He Ping, Gu Xia, Yin Weiqiang, He Jianxi
| Evaluation of Prediction of Polymorphisms of DNA Repair Genes on the Efficacy of Platinum-Based Chemotherapy in Patients With Non-Small Cell Lung Cancer: A Network Meta-Analysis.
Journal of cellular biochemistry 2017 12 118 (12): 4782-4791.
Yu Shao-Nan, Liu Gui-Feng, Li Xue-Feng, Fu Bao-Hong, Dong Li-Xin, Zhang Shu-H
| Polymorphisms in cancer-related pathway genes and lung cancer.
The European respiratory journal 2016 Sep .
Lee Shin Yup, Kang Hyo-Gyoung, Choi Jin Eun, Jung Deuk Kju, Lee Won Kee, Lee Hyun Chul, Lee So Yeon, Yoo Seung Soo, Lee Jaehee, Seok Yangki, Lee Eung Bae, Cha Seung Ick, Cho Sukki, Kim Chang Ho, Lee Myung Hoon, Park Jae Yo
| RRM1 *151A>T, RRM1 -756T>C, and RRM1 -585T>Gis associated with increased susceptibility of lung cancer in Chinese patients.
Cancer medicine 2016 Jun .
Xu Xiao-Ling, Zheng Ji, Mao Wei-Min, Ling Zhi-Qia
| Combined analysis of rearrangement of ALK, ROS1, somatic mutation of EGFR, KRAS, BRAF, PIK3CA, and mRNA expression of ERCC1, TYMS, RRM1, TUBB3, EGFR in patients with non-small cell lung cancer and their clinical significance.
Cancer chemotherapy and pharmacology 2016 Mar 77 (3): 583-93.
Zhang Quan, Sun Tianyu, Kang Poming, Qian Kai, Deng Bo, Zhou Jinghai, Wang Ruwen, Jiang Bin, Li Kun, Liu Fang, Wu Shiyang, Tan Quny
| The relationship between RRM1 gene polymorphisms and effectiveness of gemcitabine-based first-line chemotherapy in advanced NSCLC patient.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2015 Dec .
Mlak R, Krawczyk P, Ciesielka M, Kozio? P, Homa I, Powrózek T, Prendecka M, Milanowski J, Ma?ecka-Massalska
| The relationship between polymorphisms of genes regulating DNA repair or cell division and the toxicity of platinum and vinorelbine chemotherapy in advanced NSCLC patients.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2015 Jul .
Powrózek T, Mlak R, Krawczyk P, Homa I, Ciesielka M, Kozio? P, Prendecka M, Milanowski J, Ma?ecka-Massalska
| Association between epidermal growth factor receptor mutations and the expression of excision repair cross-complementing protein 1 and ribonucleotide reductase subunit M1 mRNA in patients with non-small cell lung cancer.
Experimental and therapeutic medicine 2015 Mar 9 (3): 880-884.
Xu Chun-Wei, Wang Gang, Wang Wu-Long, Gao Wen-Bin, Han Chuan-Jun, Gao Jing-Shan, Li Yang, Wang Lin, Zhang Li-Ying, Zhang Yu-Ping, Tian Yu-Wang, Fang Jin-
| Association of GSTP1 and RRM1 Polymorphisms with the Response and Toxicity of Gemcitabine-cisplatin Combination Chemotherapy in Chinese Patients with Non-small Cell Lung Cancer.
Asian Pacific journal of cancer prevention : APJCP 2015 16 (10): 4347-51.
Yuan Zhi-Jun, Zhou Wen-Wu, Liu Wei, Wu Bai-Ping, Zhao Jin, Wu Wei, He Yi, Yang Shuo, Su Jing, Luo
| Mutations of EGFR or KRAS and expression of chemotherapy-related genes based on small biopsy samples in stage IIIB and IV inoperable non-small cell lung cancer.
Journal of cancer research and clinical oncology 2014 Dec 140 (12): 2097-105.
Deng Li-Li, Deng Hong-Bin, Lu Chang-Lian, Guo Yang, Wang Di, Yan Chun-Hua, Lv Xing, Shao Yu-X
| Phase II trial of customized first line chemotherapy according to ERCC1 and RRM1 SNPs in patients with advanced non-small-cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2013 Nov 82 (2): 288-93.
Mazzoni Francesca, Cecere Fabiana Letizia, Meoni Giulia, Giuliani Costanza, Boni Luca, Camerini Andrea, Lucchesi Sara, Martella Francesca, Amoroso Domenico, Lucherini Elisa, Torricelli Francesca, Di Costanzo Frances
| Predictive value of ERCC1 and RRM1 gene single-nucleotide polymorphisms for first-line platinum- and gemcitabine-based chemotherapy in non-small cell lung cancer patients.
Oncology reports 2013 Nov 30 (5): 2385-98.
Mlak Rados?aw, Krawczyk Pawe?, Ramlau Rodryg, Kalinka-Warzocha Ewa, Wasylecka-Morawiec Maja, Wojas-Krawczyk Kamila, Kucharczyk Tomasz, Homa Iwona, Kozio? Piotr, Ciesielka Marzanna, Chudziak Dorota, Milanowski Janu
| Association of EGFR mutation or ALK rearrangement with expression of DNA repair and synthesis genes in never-smoker women with pulmonary adenocarcinoma.
Cancer 2012 Nov 118 (22): 5588-94.
Ren Shengxiang, Chen Xiaoxia, Kuang Peng, Zheng Limou, Su Chunxia, Li Jiayu, Li Bing, Wang Yongshen, Liu Lu, Hu Qiong, Zhang Jie, Tang Liang, Li Xuefei, Zhou Caicun, Schmid-Bindert Gera
| Genetic polymorphism of XRCC1 Arg399Gln is associated with survival in non-small-cell lung cancer patients treated with gemcitabine/platinum.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2012 Jun 7 (6): 973-81.
Liao Wei-Yu, Shih Jin-Yuan, Chang Gee-Chen, Cheng Yu-Kai, Yang James Chih-Hsin, Chen Yuh-Min, Yu Chong-J
| Genetic variants associated with the risk of chronic obstructive pulmonary disease with and without lung cancer.
Cancer prevention research (Philadelphia, Pa.) 2012 Mar 5 (3): 365-73.
de Andrade Mariza, Li Yan, Marks Randolph S, Deschamps Claude, Scanlon Paul D, Olswold Curtis L, Jiang Ruoxiang, Swensen Stephen J, Sun Zhifu, Cunningham Julie M, Wampfler Jason A, Limper Andrew H, Midthun David E, Yang Pi
| Gemcitabine metabolic pathway genetic polymorphisms and response in patients with non-small cell lung cancer.
Pharmacogenetics and genomics 2012 Feb 22 (2): 105-16.
Li Liang, Schaid Daniel J, Fridley Brooke L, Kalari Krishna R, Jenkins Gregory D, Abo Ryan P, Batzler Anthony, Moon Irene, Pelleymounter Linda, Eckloff Bruce W, Wieben Eric D, Sun Zhifu, Yang Ping, Wang Liew
| Association between single nucleotide polymorphisms (SNPs) and toxicity of advanced non-small-cell lung cancer patients treated with chemotherapy.
PloS one 2012 7 (10): e48350.
Zhang Ling, Gao Guanghui, Li Xuefei, Ren Shengxiang, Li Aiwu, Xu Jianfang, Zhang Jie, Zhou Caic
| Association of cytidine deaminase and xeroderma pigmentosum group D polymorphisms with response, toxicity, and survival in cisplatin/gemcitabine-treated advanced non-small cell lung cancer patients.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011 Dec 6 (12): 2018-26.
Ludovini Vienna, Floriani Irene, Pistola Lorenza, Minotti Vincenzo, Meacci Marialuisa, Chiari Rita, Garavaglia Daniela, Tofanetti Francesca Romana, Flacco Antonella, Siggillino Annamaria, Baldelli Elisa, Tonato Maurizio, Crinò Luc
| Differential effect of polymorphisms of CMPK1 and RRM1 on survival in advanced non-small cell lung cancer patients treated with gemcitabine or taxane/cisplatinum.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011 Aug 6 (8): 1320-9.
Ryu Jeong-Seon, Shin Eun-Soon, Nam Hae-Seong, Yi Hyeon-Gyu, Cho Jae-Hwa, Kim Chul-Soo, Kim Hyun-Jung, Lee Jong-E
| Single nucleotide polymorphisms in MDR1 gen correlates with outcome in advanced non-small-cell lung cancer patients treated with cisplatin plus vinorelbine.
Lung cancer (Amsterdam, Netherlands) 2011 Feb 71 (2): 191-8.
Viñolas N, Provencio M, Reguart N, Cardenal F, Alberola V, Sánchez-Torres J M, Barón F J, Cobo M, Maestu I, Moreno I, Mesía C, Izquierdo A, Felip E, López-Brea M, Márquez A, Sánchez-Ronco M, Tarón M, Santarpia M C, Rosell R,
| RRM1 single nucleotide polymorphism -37C-->A correlates with progression-free survival in NSCLC patients after gemcitabine-based chemotherapy.
Journal of hematology & oncology 2010 3 (1): 10.
Dong Song, Guo Ai-Lin, Chen Zhi-Hong, Wang Zhen, Zhang Xu-Chao, Huang Ying, Xie Zhi, Yan Hong-Hong, Cheng Hua, Wu Yi-Lo
| Polymorphisms of the ribonucleotide reductase M1 gene and sensitivity to platin-based chemotherapy in non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2009 Mar .
Feng JF, Wu JZ, Hu SN, Gao CM, Shi MQ, Lu ZH, Sun XC, Zhou JR, Chen BA
| Efficacy of gemcitabine in patients with non-small cell lung cancer according to promoter polymorphisms of the ribonucleotide reductase M1 gene.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008 May 14 (10): 3083-8.
Kim Soo-Ok, Jeong Ju-Yeon, Kim Mi-Ran, Cho Hyun-Ju, Ju Jin-Yung, Kwon Yong-Soo, Oh In-Jae, Kim Kyu-Sik, Kim Yu-Il, Lim Sung-Chul, Kim Young-Ch
| Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004 Aug 15 (8): 1194-203.
Isla D, Sarries C, Rosell R, Alonso G, Domine M, Taron M, Lopez-Vivanco G, Camps C, Botia M, Nuñez L, Sanchez-Ronco M, Sanchez J J, Lopez-Brea M, Barneto I, Paredes A, Medina B, Artal A, Lianes
| Influence of genetic markers on survival in non-small cell lung cancer.
Drugs of today (Barcelona, Spain : 1998) 2003 Oct 39 (10): 775-86.
Rosell Rafael, Taron Miquel, Camps Carlos, López-Vivanco Guiller